Literature DB >> 23150763

Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Xiang Zhou1, Jun-Ming Liao, Wen-Juan Liao, Hua Lu.   

Abstract

The oncoprotein MDM2 is both the transcriptional target and the predominant antagonist of the tumor suppressor p53. MDM2 inhibits the functions of p53 via a negative feedback loop that can be circumvented by several ribosomal proteins in response to nucleolar or ribosomal stress. Stress conditions in the nucleolus can be triggered by a variety of extracellular and intracellular insults that impair ribosomal biogenesis and function, such as chemicals, nutrient deprivation, DNA damaging agents, or genetic alterations. The past decade has witnessed a tremendous progress in understanding this previously underinvestigated ribosomal stress-MDM2-p53 pathway. Here, we review the recent progress in understanding this unique signaling pathway, discuss its biological and pathological significance, and share with readers our insight into the research in this field.

Entities:  

Keywords:  MDM2; MDMX; MDS; cancer; nucleolar stress; p53; ribosomal proteins; ribosomopathy

Year:  2012        PMID: 23150763      PMCID: PMC3494370          DOI: 10.1177/1947601912455200

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  133 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.

Authors:  D G Pestov; Z Strezoska; L F Lau
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 3.  Making ribosomes.

Authors:  Alessandro Fatica; David Tollervey
Journal:  Curr Opin Cell Biol       Date:  2002-06       Impact factor: 8.382

4.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  The p53-mdm-2 autoregulatory feedback loop.

Authors:  X Wu; J H Bayle; D Olson; A J Levine
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

6.  Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.

Authors:  J D Weber; M L Kuo; B Bothner; E L DiGiammarino; R W Kriwacki; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

7.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

9.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  35 in total

Review 1.  Role of the nucleus in apoptosis: signaling and execution.

Authors:  Evgeniia A Prokhorova; Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2015-09-07       Impact factor: 9.261

2.  Haploinsufficiency screen highlights two distinct groups of ribosomal protein genes essential for embryonic stem cell fate.

Authors:  Simon Fortier; Tara MacRae; Mélanie Bilodeau; Tobias Sargeant; Guy Sauvageau
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 3.  Negative auto-regulators trap p53 in their web.

Authors:  Xiang Zhou; Bo Cao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

4.  A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Authors:  Konstantinos Karakostis; Sivakumar Vadivel Gnanasundram; Ignacio López; Aikaterini Thermou; Lixiao Wang; Karin Nylander; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

Review 5.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

6.  Loss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcription.

Authors:  Karl Holmberg Olausson; Monica Nistér; Mikael S Lindström
Journal:  J Biol Chem       Date:  2014-10-27       Impact factor: 5.157

Review 7.  GRWD1, a new player among oncogenesis-related ribosomal/nucleolar proteins.

Authors:  Takuya Takafuji; Kota Kayama; Nozomi Sugimoto; Masatoshi Fujita
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

8.  Antitumor effect of miR-197 targeting in p53 wild-type lung cancer.

Authors:  M E Fiori; C Barbini; T L Haas; N Marroncelli; M Patrizii; M Biffoni; R De Maria
Journal:  Cell Death Differ       Date:  2014-01-31       Impact factor: 15.828

9.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

Review 10.  New insights into p53 functions through its target microRNAs.

Authors:  Jun-Ming Liao; Bo Cao; Xiang Zhou; Hua Lu
Journal:  J Mol Cell Biol       Date:  2014-04-15       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.